Agilent Restructures, Laying off 450; Q2 Revenues Flat | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies announced after the close of the market on Tuesday a restructuring program expected to reduce its headcount by about 450 employees and save the company $50 million annually in operating expenses.

The Santa Clara, Calif.-based firm also reported that revenues were flat year over year in its fiscal second quarter and that its board approved an additional $500 million to its existing share buy-back program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.